Di Donato V, Bellati F, Casorelli A, Giorgini M, Perniola G, Marchetti C, Palaia I, Benedetti Panici P. CO2 laser treatment for Bartholin gland abscess: ultrasound evaluation of risk recurrence.
J Minim Invasive Gynecol 2013;
20:346-52. [PMID:
23380446 DOI:
10.1016/j.jmig.2012.12.003]
[Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2012] [Revised: 12/08/2012] [Accepted: 12/10/2012] [Indexed: 11/25/2022]
Abstract
STUDY OBJECTIVE
To evaluate the efficacy of CO2 laser treatment and parameters correlated with recurrence in patients with Bartholin gland abscesses treated using this approach.
DESIGN
Prospective study (Canadian Task Force classification II-2).
SETTING
University hospital.
PATIENTS
One hundred forty-seven patients who met eligibility criteria.
INTERVENTION
Preoperative ultrasound evaluation of Bartholin gland lesions and CO2 laser treatment.
MEASUREMENTS AND MAIN RESULTS
All patients received CO2 laser therapy, with median operative time 15 minutes (range, 12-35 minutes). Median postoperative stay was 1 hours (range, 1-4 hours). Estimated 3-year relapse-free rate was 88.56%. Lesion wall thickness 0.5-1.5 mm, multilocular lesion, and hyperechogenic lesion were correlated with recurrence.
CONCLUSION
CO2 laser of Bartholin gland abscesses could be a valid option. Ultrasound characteristics of Bartholin gland lesions could predict lesion recurrence rate.
Collapse